NIHR news icon green

i4i Connect: funding for SMEs to accelerate medical technology development

Date: 08 August 2017

The NIHR Invention for Innovation (i4i) Programme is launching a new funding stream - i4i Connect - aimed at small and medium-sized enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway.

Offering up to £150,000 over a 6-12 month period, i4i Connect will help SMEs get to the point of eligibility for a full i4i award or, down the line, follow on-funding. This will enable accelerated development of promising medical technologies, in line with recommendations from the Government’s Accelerated Access Review.

Martin Hunt, NIHR i4i Programme Director said:

“SMEs have told us that there is a gap in funding both in the early stage of development and for completed projects that do not have all the data to effectively access the follow-on funding marketplace. i4i Connect will support teams through either of these stages of development with a fast turnaround of funding - vital for SMEs needing to maintain momentum.

“The NIHR will provide a maximum of £150,000 short term funding for SMEs with innovative technologies in the pipeline. This new funding will help SMEs get to the next stage of investment, supporting accelerated development to ensure technologies benefit patients sooner.”

NIHR’s i4i Programme is a translational funding scheme that supports healthcare technologies, devices and interventions for patient benefit in areas of existing or emerging clinical need. The aim is to de-risk projects, making them attractive to follow-on funders and investors. i4i Connect is specifically tailored for SMEs at this later point of product development, as well as in the early stage to provide support on the pathway to full i4i funding, with an NHS or academic partner.

Ian Mawhinney, CEO at SME Rapid Rhythm Ltd said:

 "The funding and support we received from the i4i Programme was integral to the successful development of our Rapid Rhythm System - a diagnostic ECG for rapid diagnosis and treatment of heart conditions such as atrial fibrillation, a major cause of stroke.

“UK SME’s are a real source of innovation in healthcare. It's great to hear the NIHR are launching funding specifically to meet the needs of SMEs, and I think it will be very well received within the community.”

Richard Stubbs, CEO Yorkshire and Humber Academic Health Science Network said:

“Speeding up access to groundbreaking medical technology is a vital component of a transformed, sustainable NHS. SME innovators are developing the health technologies of our future, and funding such as the NIHR’s i4i Connect will support them by bridging the gap between early stage development and market readiness.”

i4i Connect launches in addition to the £86m funding commitment made this month by the UK Government for healthcare SMEs to develop new medicines and technologies for use in the NHS.

The i4i Connect funding call is now open, SMEs will have until 13 September to submit an expression of interest. Successful applicants will then be invited to submit a business case and video pitch. Full details of the programme, key dates and application process will be on the i4i webpage.

  • Summary:
    The NIHR Invention for Innovation (i4i) Programme is launching a new funding stream - i4i Connect - aimed at small and medium-sized enterprises (SMEs) in need of a funding boost to reach their next stage in the development pathway.
  • Include on homepage (one at a time):
  • Areas of the site this news is applicable to:
  • LCRN:
    • North West Coast
    • North West London
    • South London
    • South West Peninsula
    • Thames Valley and South Midlands
    • Wessex
    • West Midlands
    • West of England
    • Yorkshire and Humber
    • North Thames
    • North East and North Cumbria
    • Kent, Surrey and Sussex
    • Greater Manchester
    • Eastern
    • East Midlands
  • Year of publication:
  • Specialty:
    • Antimicrobial Resistance
    • Cancer
    • Cardiovascular Disease
    • Children
    • Complex needs
    • Congenital Disorders
    • Critical Care
    • Dementias and Neurodegeneration - DeNDRoN
    • Dermatology
    • Diabetes
    • Ear, Nose and Throat
    • Gastroenterology
    • Genetics
    • Haematology
    • Health Services and Delivery Research
    • Hepatology
    • Infectious Diseases and Microbiology
    • Inflammatory Disease
    • Injuries and Emergencies
    • Long-term conditions in children
    • Mental Health
    • Mesothelioma
    • Metabolic and Endocrine Disorders
    • Musculoskeletal Disorders
    • Neurological Disorders
    • Obesity
    • Ophthalmology
    • Oral and Dental Health
    • Primary Care
    • Public Health
    • Renal Disorders
    • Reproductive Health and Childbirth
    • Respiratory Disorders
    • Social Care
    • Stroke
    • Surgery
    • Very rare diseases
    • Anaesthesia, Perioperative Medicine and Pain Management
    • Ageing

You may also be interested in